glp 1 drug mechanism of action GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Recent updates on GLP-1 agonists:

Eating whole grains, fruits, vegetables, and lean proteins will activate that fullness factor

Comparison of the decrease in glycated hemoglobin levels of diabetic patients caused by a 40-week treatment with tirzepatide (5, 10 or 15 mg/wk) or semaglutide (1 mg/wk)

November 2023 : Eli Lilly received US FDA approval for ZEPBOUND, an obesity treatment that activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors

Understanding how GLP-1 medications compare to older weight loss drugs like phentermine also helps frame the conversation

Products marketed as personalized blends with added vitamins or other ingredients, without a clear clinical rationale, are often designed to tout those additions to sidestep regulations rather than to benefit the patient